A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer

Abstract Improved and cheaper molecular diagnostics allow the shift from “one size fits all” therapies to personalised treatments targeting the individual tumor. However, the wealth of potential targets based on comprehensive sequencing remains a yet unsolved challenge that prevents its routine use...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Friedemann Krentel, Franziska Singer, María Lourdes Rosano-Gonzalez, Ewan A. Gibb, Yang Liu, Elai Davicioni, Nicola Keller, Daniel J. Stekhoven, Marianna Kruithof-de Julio, Roland Seiler
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7cf4534a1f14476c80ba0dde9465c1d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!